Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
Taken together , our model predicts that the best candidates for adding GLP-1 M as a second line T2D medication are: older age, non-Asian subjects, with short T2D duration that have elevated HbA1C, high BMI, hypertension, and no heart failure or retinopathy
3 Immunological characteristics and pathophysiology of SLE Understanding the characteristics and pathogenesis of SLE deepens our knowledge of this complex autoimmune disease
Both have traditionally been used for athletic performance, but their role in medical treatment, particularly in cancer, is now being investigated more closely
11 January 2024
Tirzepatide: A dual-action medication combining GLP-1 and GIP receptor agonists, used for diabetes and weight management
US$ 21.33
US$ 23.14
US$ 27.55
US$ 25.73
US$ 23.44
US$ 26.75
US$ 25.61
US$ 24.58
US$ 28.43
US$ 26.80
US$ 20.03
US$ 27.97
US$ 22.55
